Group | Chi-square | ||||||||||||
AR | AS | AF | X2 | P-value | |||||||||
N | % | N | % | N | % | ||||||||
TM | NO | 77 | 77.0% | 66 | 66.0% | 78 | 78.0% | 13.812 | 0.032* | ||||
G I | 12 | 12.0% | 13 | 13.0% | 3 | 3.0% | |||||||
G II | 9 | 9.0% | 15 | 15.0% | 12 | 12.0% | |||||||
G III | 2 | 2.0% | 6 | 6.0% | 7 | 7.0% | |||||||
FI | NO | 69 | 69.0% | 60 | 60.0% | 60 | 60.0% | 6.084 | 0.638 | ||||
G I | 15 | 15.0% | 17 | 17.0% | 18 | 18.0% | |||||||
G II | 11 | 11.0% | 13 | 13.0% | 18 | 18.0% | |||||||
G III | 4 | 4.0% | 8 | 8.0% | 3 | 3.0% | |||||||
G IV | 1 | 1.0% | 2 | 2.0% | 1 | 1.0% | |||||||
TFO | NE | 94 | 94.0% | 90 | 90.0% | 96 | 96.0% | 2.959 | 0.228 | ||||
PO | 6 | 6.0% | 10 | 10.0% | 4 | 4.0% | |||||||
BC | NO | 78 | 78.0% | 77 | 77.0% | 78 | 78.0% | 0.038 | 0.981 | ||||
PO | 22 | 22.0% | 23 | 23.0% | 22 | 22.0% | |||||||
L20RT | NO | 98 | 98.0% | 83 | 83.0% | 94 | 94.0% | 15.923 | <0.001* | ||||
PO | 2 | 2.0% | 17 | 17.0% | 6 | 6.0% | |||||||
ANOVA test | |||||||||||||
|
|
| F | P value | |||||||||
PPD | AR | 3.660 ± 0.913 | 5.713 | 0.004* | |||||||||
AS | 4.175 ± 1.173 | ||||||||||||
AF | 3.910 ± 1.129 | ||||||||||||
Chi-square | |||||||||||||
|
| AR | AS | AF | X2 | P-value | |||||||
N | % | N | % | N | % | ||||||||
(PBL) | Absent | 35 | 35% | 17 | 17.0% | 30 | 30.0% | 18.265 | 0.006* | ||||
H | 49 | 49% | 66 | 66.0% | 52 | 52.0% | |||||||
V | 7 | 7% | 2 | 2.0% | 1 | 1.0% | |||||||
H + V | 9 | 9% | 15 | 15.0% | 17 | 17.0% | |||||||